Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most effective places to inject Wegovy (semaglutide) are the abdomen, front of the thigh, and upper outer arm. All three sites are clinically approved in the prescribing information, and evidence does not show one produces meaningfully more weight loss than another. What matters most is rotating sites within each area and injecting consistently, week to week. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy's UK prescribing information lists three areas where subcutaneous injection is appropriate: the abdomen (excluding the two inches directly around the navel), the front of the thigh, and the upper outer arm. The NHS semaglutide medicines page describes these same sites and confirms that the pen should be pressed firmly against clean, dry skin before activating.
There is no clinical evidence that one site delivers better weight-loss results than another. The active ingredient, semaglutide, enters the bloodstream from all three locations. What differs between sites is practical: the abdomen is usually the simplest to reach without help, the thigh works well if you prefer to sit during injection, and the upper arm is often chosen by people who find the other two uncomfortable — though a partner or carer may need to assist with that one.
Speed of absorption can vary very slightly between sites, but this fluctuation is small and does not translate into a meaningful clinical difference for once-weekly dosing. The Wegovy SmPC on the eMC makes no recommendation to prefer one site over another for efficacy. Stick to the areas listed; never inject into muscle, a vein, or an area of damaged or irritated skin.
If you inject into exactly the same spot each week, the tissue beneath the skin can harden, a condition called lipohypertrophy. Hardened tissue absorbs medicine less predictably. Rotating systematically prevents this and keeps absorption consistent over months of treatment.
A simple approach: divide the abdomen into four quadrants and move clockwise week to week, or alternate between the left and right thigh on successive injections. Many people find it useful to keep a brief record, even just a note on their phone, until rotation becomes habit. Our prescribers often describe this as one of the practical points patients say they wished someone had mentioned at the start.
If you notice any persistent lump, redness, or skin change at an injection site, rest that area until it has fully settled before using it again, and flag it at your next clinical check-in. You can also read about choosing your site to minimise injection-side effects for more detail on managing skin reactions.
The where matters, but so does the how. A few practical points make a consistent difference across all three sites.
Clean the area first with an alcohol swab and let it dry fully before injecting, residual alcohol can sting. Alcohol swabs are worth keeping alongside your pen. If you have a slender build or are injecting into the thigh, pinching the skin gently between thumb and forefinger before pressing the pen helps ensure the medicine reaches subcutaneous fat rather than muscle. Inject at the angle specified in the patient leaflet that comes with your pen, do not try to adapt technique from general guidance you may have read for insulin.
Hold the pen in place for the full count after activation before removing it; lifting it early can cause leakage at the injection site. After removing the pen, press lightly with a finger or clean gauze but do not rub. Rubbing can disperse the medicine too quickly and may increase local soreness. Dispose of used pens in an appropriate sharps container, household bins are not safe or legal for sharps waste.
Storage affects the medicine before it even reaches your skin. Wegovy should be kept refrigerated; check the patient information leaflet for the permitted period out of the fridge. Never inject a pen that has been frozen, and keep it away from direct light.
Choosing an injection site is one of the smaller decisions on this journey, but it is worth getting right from the first dose. If you are still deciding whether injectable semaglutide or a different route suits you better, it helps to understand the full picture of how Wegovy works alongside the practical side of weekly injections.
Cost is a real part of that thinking for most people. A quick look at the Wegovy price comparison page sets out what private treatment typically costs and what the differences between providers reflect. For context on the broader landscape of weekly weight-loss injections, this overview of semaglutide and related medicines covers the key distinctions clearly.
If you would like to understand which area of the abdomen tends to work best for Wegovy, that page goes into more granular detail on site selection within the abdomen specifically. For a broader breakdown of injection spot options, the guide to injection site selection for Wegovy covers the comparison across all three areas in one place.
Wegovy is a prescription-only medicine. Suitability, dosing, and any changes to your injection routine are decisions made with your prescriber, not by the injection site you choose. If you are ready to explore whether treatment is right for you, check your eligibility with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.